Pharmacogenomics of neuroimmune interactions in human psychiatric disorders (Q36901407)

17 August 2017

1 reference

title

Pharmacogenomics of neuroimmune interactions in human psychiatric disorders (English)

1 reference

17 August 2017

1 reference

3

1 reference

PubMed ID

17675415

17 August 2017

Claudio A. Mastronardi

object named as

Claudio Mastronardi

series ordinal

2

0 references

Julio Licinio

object named as

Julio Licinio

series ordinal

1

0 references

publication date

3 August 2007

1 reference

17 August 2017

Experimental Physiology

1 reference

17 August 2017

92

1 reference

17 August 2017

807-811

1 reference

17 August 2017

5

1 reference

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

17 August 2017

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Effects of antidepressants on cytokine production and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Cytokine dysregulation, inflammation and well-being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Pathways and mechanisms for cytokine signaling of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Interleukin 1 receptor antagonist gene expression in rat pituitary in the systemic inflammatory response syndrome: pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Endogenous interleukin-1 receptor antagonist is neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Caspase 1 deficiency reduces inflammation-induced brain transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

"Inflammatory" cytokines: neuromodulators in normal brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Inducible nitric oxide synthase gene expression in the brain during systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

Localization of interleukin 1 type I receptor mRNA in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038471

10.1113/EXPPHYSIOL.2007.038471

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17675415